期刊文献+

人源肠毒素大肠杆菌CS3纤毛基因的克隆及表达 被引量:15

CLONING AND EXPRESSION OF THE GENE ENCODING CS3 FIMBRIAE ANTIGEN OF ENTEROTOXIGENIC ESCHERICHIA COLI
原文传递
导出
摘要 Southern印迹结果证明在CFA/Ⅱ阳性菌E44815的诸多质粒中,编码CS3纤毛抗原的质粒为一约为60MD的大质粒;当这些质粒用HindⅢ消化时,该抗原的编码基因位于5.0kb的DNA片段上。回收该片段并插入到载体质粒pBR322的HindⅢ位点,构建了E.coliE44815株质粒的有限基因库。通过筛选,获得了两种插入方向的阳性重组子。全细胞ELISA测定结果表明,只有当插入片段的转录方向和载体质粒中的p1启动子的转录方向一致时,重组质粒才能有效地表达CS3纤毛抗原;宿主不同时表达水平存在一定差异。SDS-PAGE及Western印迹试验表明:CS3纤毛抗原有两种不同的单体形式,分子量大约分别为15.0kD和15.5kD。CS3纤毛抗原编码基因的克隆为研究CS3基因表达调控和研制预防ETEC腹泻疫苗打下了基础。 The results of Southern blot revealed that the CS3 antigen was coded by a large plasmid(60MD) isolated fromE44815 strain , and the DNA fragment containing the gene encoding CS3 fimbriae was about 5.0 kb when the plas-mid was digested by Hind Ⅲ.Limited gene bank was constructed by recovering all the DNA fragments of about5.0 kb after the plasmid was digested and inserting it into the Hind Ⅲ site of pBR322.Through screening,we ob-tained two kinds of positive recombinant plasmids harbouring the cloned fragment in opposite orientation. Wholecell ELISA demonstrated that only when the orientation of transcription of the cloned fragment was identical withthat of P1 promoter in the pBR322, could the CS3 antigen be expressed.And the test also demonstrated that thelevel of expression of CS3 antigen were different due to different on hosts.SDS-PAGE assay and Western blotidentified that CS3 antigen had two different forms and the molecular weight were l5 kD and 15.5 kD, respective-ly. Cloning of the gene encoding CS3 antigen permits us to study the regulation of its expression and to constructvaccine against ETEC.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 1994年第2期84-88,共5页 Chinese Journal of Microbiology and Immunology
关键词 ETEC CS3 重组克隆 基因表达 ETEC CS3 Genetic cloning Expression of gene
  • 相关文献

参考文献1

  • 1李淑琴,解放军医学杂志,1988年,13卷,271页

同被引文献39

  • 1阮力 旺垣 等.新型疫苗研究的现状及展望[M].北京:科学出版社,1992.171-183.
  • 2阮力 汪垣 等.新型疫苗研究的现状与展望[M].北京:科学出版社,1992.171-183.
  • 3Gaastra W, Svennerholm A M. Colonization factors of human enterotoxigenic Escherichia coli ( ETEC ). Trends in Microbioi,1996, 4 (11): 444~452.
  • 4WHO. New frontiers in the development of vaccines agaist enterotoxingenic (ETEC) and enterohaemorrhagic, (EHEC) E.coli infections. Weekly Epidemiological Record. 1999, (3): 98--101.
  • 5Qadri F, Wermeras C, Ahmed F, et al. Safety and immunogenicity of an oral, inactivated enterotoxiganic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi adults and children. Vaccine, 2000, 18 (24): 2704--2712.
  • 6Sanchez J, Johansson S, Lowenadler B, et al. Recombinant cholera toxin B subunit and gene fusion proteins for oral vaccination. Res Microbiol, 1990, 141 (8--9): 971--979.
  • 7Shi C H, Cao C, Zhig J S, et al. Gene fusion of cholear toxin B subunit and HBV PreS2 epitope and the antigenicity of fusion protein. Vaccine, 1995, 13 (10): 933~937.
  • 8Sambrook J, Russell D W. Molecular Cloning: A Laboratory Manual. 3th. New York: Cold Spring Harbor Laboratory Press,2001. 34--69.
  • 9Jagnsztyn-Krynicka E K, Clark-Curtiss J E, Curtiss R 3rd .Escherichia coli heat-labile toxin subtmit B fusions with Streptococcus sobrinus antigens expressed by Salmonella typhimurium oral vaccine strains: importance of the linker for antigenicity and biological activitese of the hybrid proteins. Infect Immun, 1993, 61 (3): 1004--1015.
  • 10Liljeqvist S, Stahl S, Andreoni C, et al. Fusions to the cholera toxin B subunit: influence on pentamerization and GM1 binding. J Immun Meth, 1997, 210 (2): 125--135.

引证文献15

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部